Home / Top News / HealthTech Leaders: Reliq, Teladoc, WELL Health and AI/ML Innovations; CEO’s Driving Revenue Growth Momentum & Digital Health Innovation

HealthTech Leaders: Reliq, Teladoc, WELL Health and AI/ML Innovations; CEO’s Driving Revenue Growth Momentum & Digital Health Innovation

NEW YORK, Sept. 08, 2021 (GLOBE NEWSWIRE) — Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Reliq Health Technologies (OTC: RQHTF) (TSX.V: RHT), Teladoc Health (NYSE: TDOC), AI/ML Innovations (OTC: AIMLF) (CSE: AIML) and WELL Health Technologies (TSX: WELL) (OTC: WLYYF).

AI/ML Innovations (OTC: AIMLF) (CSE: AIML) Chairman, Tim Daniels: “Mental Health App Expands AI/ML Digital Health Ecosystem – Targeting Multi-Billion Dollar Market Opportunities”

NEXT SUPER STOCK conference presenter AI/ML Innovations (OTC: AIMLF) (CSE: AIML) is rapidly expanding its portfolio of HealthTech assets. AIMLF chairman Tim Daniels updated investors on the company’s latest digital healthcare growth initiatives, which now includes Tech2Health, a European mental health app innovator. Tech2Health is positioned for explosive revenue growth as European healthcare mandates now provide about 2,500 Euro per patient annually for mental wellness. Tech2Health has just signed with a French multinational manufacturer to provide mental wellness support to their 170,000 employees globally, and additional Enterprise contracts are in the pipeline.

Watch AI/ML Innovations (OTC: AIMLF) (CSE: AIML) NEXT SUPER STOCK Video: https://bit.ly/3dAI6k9

AIMLF Chairman Tim Daniels shared with investors how AIMLF is expanding its global digital healthcare footprint with synergistic acquisitions of innovative HealthTech companies. Tim also updated investors on progress at AIMLF’s HealthGauge platform which uses AI and machine learning for applications ranging from remote patient monitoring, to fitness/health tracking and more. AIMLF focus is on scaling revenue growth, by offering its services to enterprise and consumers via a SaaS recurring revenue subscription model. Tim Daniels also updated investors on AIML’s growing pipeline of M&A opportunities in the HealthTech space, which could have a positive impact on maximizing shareholder value in coming months.

Watch AI/ML Innovations (OTC: AIMLF) (CSE: AIML) NEXT SUPER STOCK Video: https://bit.ly/3dAI6k9

Teladoc Health (NYSE: TDOC) CEO Jason Gorevic: “Teladoc is Leading Digital Transformation of Healthcare”

“…Strong momentum across our channels and geographies gives us the confidence and visibility to increase our full year revenue guidance to $2.0 billion to $2.025 billion… Teladoc’s aim is to provide whole-person virtual care. And during the second quarter, we continued to demonstrate progress on achieving our goal of completely reimagining the health care experience… The number of members enrolled in the Livongo suite of products grew 45% year-over-year to 715,000. Rather than focus on one particular disease, our approach is to treat the whole person in an integrated manner, which is important given that over 40% of adults in the U.S. are living with multiple chronic conditions.”

“…As a result of this approach, we continue to drive significant growth in multi-program enrollment. Over 20% of our chronic care members are now enrolled in more than one program, up from 6% in the second quarter of last year. The growth in chronic care members, combined with the greater number of individuals enrolled in multiple programs, such as members enrolled in both our diabetes and hypertension programs, resulted in a 60% year-over-year increase in the total number of chronic programs in which our members are enrolled…Most importantly, our services are driving better outcomes. For example, in a recent survey of over 2,000 consumers of our virtual mental health services, more than 90% of those who sought care experienced improvement, with nearly 40% experiencing a significant breakthrough during treatment…”

Teladoc Health (NYSE: TDOC) Earnings Call Highlights Available at: https://bit.ly/3zdanWH

Reliq Health Technologies (OTC: RQHTF) (TSX.V: RHT) CEO Lisa Crossley: “2021 is Breakout Year for Reliq Telehealth Platform”

Reliq Health Technologies (OTC:RQHTF) is now at an inflection point for explosive revenue growth and profitability shared CEO Lisa Crossley during a recent presentation at Wall Street Reporter’s NEXT SUPER STOCK livestream. RQHTF’s iUGO telehealth remote patient monitoring platform has gained significant traction over the past 6 months, and now has 200,000 patients under contract to be onboarded over the next 18-24 months – which represents over $120 Million in recurring annual revenue at full deployment.

Watch Reliq Health Tech (OTC:RQHTF) (TSX.V:RHT) NEXT SUPER STOCK Video: https://bit.ly/3BcFkLi

RQHTF has just turned the corner to profitability and revenues are expected to reach $2 million per month revenues, hitting a $24 million run rate by the end of December – and keep increasing as more contracted patients are onboarded. Lisa added that RQHTF is now starting to throw off significant cash flow, enabling the company to fund growth internally, without the need for capital raises in the near future. A NASDAQ uplisting remains a possibility for 2022.

Lisa explained how new patient contract growth is now “snowballing” – powered by expanded medicare and medicaid coverage and reimbursement amounts for virtual care services like RQHTF provides. RQHTF’s powerful iUGO telemedicine platform supports care coordination and community-based virtual healthcare, allows complex patients to receive high quality care at home, improving health outcomes, and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.

Watch Reliq Health Tech (OTC:RQHTF) (TSX.V:RHT) NEXT SUPER STOCK Video: https://bit.ly/3BcFkLi

WELL Health Technologies (TSX: WELL) (OTC: WLYYF) “The ‘Berkshire Hathaway’ of Tech-Enabled Health Care – On Track to $400 Million Revenues”

“…We regard ourselves, aspirationally, as the Berkshire Hathaway tech-enabled health care. Much like Berkshire Hathaway, our goal is to make investments in highly successful and resilient companies run by top-notch management teams that have a superior track record of delivering results. The main difference here is that Berkshire has a very wide mandate and ours is very much focused on the theme of tech-enabled healthcare, as we see this as a pivotal time, where digitization and modernization are occurring in one of the largest sectors in the world…”

“…WELL’s goals for 2021: One, is to drive organic growth across all our business units and again, using the opportunity to cross-fertilize and leverage new opportunities through the network effects brought about by our growing network. Two, continue to follow a very disciplined acquisition and capital allocation strategy. Three, increase EBITDA throughout the year. Four, increase operating cash flows through acquisitions, optimizing costs and digitizing clinical assets. And five, increasing our market share of digital health and virtual care-related products and programs.

“Our outlook remains very positive across all our business units. We continue to have approximately 9 executed LOIs signed and pending for execution. The value of these LOIs when combined with our existing deals propels us to well over $400 million in revenue and over $100 million in EBITDA. Given the strong scale, WELL continues to seriously evaluate the prospects and feasibility of a U.S. IPO in the next few months…”

WELL Health Technologies Corp. (TSX: WELL) (OTC: WLYYF) Earnings Highlights: https://bit.ly/3604nnc


Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO’s of promising, publicly-traded companies, and market experts. www.WallStreetReporter.com. Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Full disclaimer, and relevant SEC 17B disclosures here: http://bit.ly/39kkE7K

About Wall Street Reporter’s Next Super Stock conference:

Wall Street Reporter’s NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/

(212) 871-2057 ext. 7